In the 12 months to Nov 19, 2026, on the open market: bought $1.6M of KTTA, BOLT, ADIL. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $1.6MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
KTTABought: Pasithea Therapeutics Corp. Nov 17, 2026875,000 sharesfiled Nov 17, 20265,502,549 shares held indirectly after, as filedfiling$411K
BOLTBought: Bolt Biotherapeutics, Inc. Nov 17, 202620,000 sharesfiled Nov 17, 2026515,510 shares held indirectly after, as filedfiling$115K
KTTABought: Pasithea Therapeutics Corp. Nov 16, 2026583,083 sharesfiled Nov 17, 20264,627,549 shares held indirectly after, as filedfiling$291K
BOLTBought: Bolt Biotherapeutics, Inc. Nov 16, 202633,094 sharesfiled Nov 17, 2026495,510 shares held indirectly after, as filedfiling$195K
KTTABought: Pasithea Therapeutics Corp. Nov 13, 2026209,431 sharesfiled Nov 17, 20264,044,466 shares held indirectly after, as filedfiling$104K
BOLTBought: Bolt Biotherapeutics, Inc. Nov 9, 202650,000 sharesfiled Nov 10, 2026462,416 shares held indirectly after, as filedfiling$319K
ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 16, 20261,233 sharesfiled Jul 16, 2026388,308 shares held indirectly after, as filedfiling$3K
ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 14, 20262,000 sharesfiled Jul 16, 2026387,075 shares held indirectly after, as filedfiling$5K
ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 10, 20261,700 sharesfiled Jul 13, 2026385,075 shares held indirectly after, as filedfiling$5K
ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 9, 202610,053 sharesfiled Jul 13, 2026383,375 shares held indirectly after, as filedfiling$28K
ADILBought: ADIAL PHARMACEUTICALS, INC. Jun 29, 202625,000 sharesfiled Jul 1, 2026373,322 shares held indirectly after, as filedfiling$65K
KTTABought: Pasithea Therapeutics Corp. Jun 17, 2026100,000 sharesfiled Jun 22, 20263,835,035 shares held indirectly after, as filedfiling$53K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G
CAMPCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: CAMP4 Therapeutics Corporationfiling9.99%
ELOXCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: Eloxx Pharmaceuticals, Inc.filing9.99%
XFORCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: X4 Pharmaceuticals, Inc.filing9.99%
ANTXCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: AN2 Therapeutics, Inc.filing9.99%
XLOCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: Xilio Therapeutics, Inc.filing9.99%
NERVCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: Minerva Neurosciences, Inc.filing9.99%
WHWKCoastlands Capital LP filed Nov 13, 2026Schedule 13G/Apassiveissuer: Whitehawk Therapeutics, Inc.filing6.19%
STROCoastlands Capital LP filed Nov 9, 2026Schedule 13Gpassiveissuer: Sutro Biopharma, Inc.filing5.14%
BOLTCoastlands Capital LP filed Nov 6, 2026Schedule 13Gpassiveissuer: Bolt Biotherapeutics, Inc.filing17.5%
AZRCoastlands Capital LP filed Nov 3, 2026Schedule 13G/Apassiveissuer: Azora Therapeutics, Inc.filing4.99%
Coastlands Capital LP filed Nov 2, 2026Schedule 13G/Apassiveissuer: Azora Therapeutics, Inc.filing4.99%
KLRSCoastlands Capital LP filed Oct 26, 2026Schedule 13Gpassiveissuer: Kalaris Therapeutics, Inc.filing5.69%
FLSCCoastlands Capital LP filed Oct 16, 2026Schedule 13Gpassiveissuer: Frazier Life Sciences Acquisition Corp. IIfiling6.41%
IBIOCoastlands Capital LP filed Oct 14, 2026Schedule 13Gpassiveissuer: iBio, Inc.filing9.72%
OKURCoastlands Capital LP filed Oct 7, 2026Schedule 13Gpassiveissuer: OnKure Therapeutics, Inc.filing6.67%
PYXSCoastlands Capital LP filed Oct 5, 2026Schedule 13Gpassiveissuer: Pyxis Oncology, Inc.filing5.42%